logo-loader
viewGilead Sciences, Inc.

S&P/ASX 200 futures down 1.2% heading into the open, US markets fall overnight

The S&P 500 closed down 2.93% and the Nasdaq Composite closed down 0.27%.

Gilead Sciences, Inc. - S&P/ASX 200 futures down 1.2% heading into the open as US markets fall
Gold was a big winner overnight, up 5.1% but US markets were down as Congress doesn't pass stimulus bill

S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) futures are down 1.2% heading into the open but have rebounded from their earlier lows with optimistic investors calling for a bounce today.

Overnight, the S&P 500 Index (INDEX:. INX) closed at 2,237.40, −67.52 or down 2.93% and the Nasdaq Composite (INDEXNASDAQ: .IXIC) closed at 6,860.67, −18.84 or down 0.27%.

With two red sessions in the US now on Friday and Monday, the market is due for good news.

US Congress is debating an economic stimulus bill, which when passed could provide the reprieve the market desperately needs short term.

Alternatively, the market may focus on the US FDA this morning granting potential COVID19 treatment drug Remdesivir with an Orphan Drug Designation.

Remdesivir is a novel antiviral drug developed by Gilead Sciences, Inc. (NASDAQ:GILD).

Gold and oil higher overnight

Gold was up 5.1% overnight to US$1,560 per ounce and Crude Oil WTI was up 5.1% to US$23.80 per barrel.

The AUD is buying 58.2 US cents which is largely unchanged at -0.2% overnight.

 

 

 

 

 

Quick facts: Gilead Sciences, Inc.

Price: 77.54 USD

NASDAQ:GILD
Market: NASDAQ
Market Cap: $97.26 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Archer Materials looking to raise 3 million offering a Share Purchase Plan

Archer Materials ( ASX: AXE) CEO Dr Mohammad Choucair joined Proactive’s Steve Darling with news the company is looking to raise capital in a Share Purchase Plan which began June 1st. That plan will allow eligible shareholders the opportunity to purchase new Archer shares at a price of $0.60 per...

40 minutes ago

2 min read